Adam A - Search Results

1

Expression of metallopeptidases and kinin receptors in swine oropharyngeal tissues: effects of angiotensin I-converting enzyme inhibition and inflammation.

Moreau ME, Dubreuil P, Molinaro G, Chagnon M, Müller-Esterl W, Lepage Y, Marceau F, Adam A. Moreau ME, et al. Among authors: adam a. J Pharmacol Exp Ther. 2005 Dec;315(3):1065-74. doi: 10.1124/jpet.105.088005. Epub 2005 Sep 15. J Pharmacol Exp Ther. 2005. PMID: 16166273

2

Role of nuclear factor-kappaB and protein kinase C signaling in the expression of the kinin B1 receptor in human vascular smooth muscle cells.

Moreau ME, Bawolak MT, Morissette G, Adam A, Marceau F. Moreau ME, et al. Among authors: adam a. Mol Pharmacol. 2007 Mar;71(3):949-56. doi: 10.1124/mol.106.030684. Epub 2006 Dec 18. Mol Pharmacol. 2007. PMID: 17178924

3

The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes.

Désormeaux A, Moreau ME, Lepage Y, Chanard J, Adam A. Désormeaux A, et al. Among authors: adam a. Biomaterials. 2008 Mar;29(9):1139-46. doi: 10.1016/j.biomaterials.2007.11.019. Biomaterials. 2008. PMID: 18078988 Free PMC article.

4

Vasopeptidase inhibitors: a new class of dual zinc metallopeptidase inhibitors for cardiorenal therapeutics.

Molinaro G, Rouleau JL, Adam A. Molinaro G, et al. Among authors: adam a. Curr Opin Pharmacol. 2002 Apr;2(2):131-41. doi: 10.1016/s1471-4892(02)00138-8. Curr Opin Pharmacol. 2002. PMID: 11950623 Review.

5

Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin.

Molinaro G, Cugno M, Perez M, Lepage Y, Gervais N, Agostoni A, Adam A. Molinaro G, et al. Among authors: adam a. J Pharmacol Exp Ther. 2002 Oct;303(1):232-7. doi: 10.1124/jpet.102.038067. J Pharmacol Exp Ther. 2002. PMID: 12235256 Free article.

6

Protective effect of omapatrilat, a vasopeptidase inhibitor, on the metabolism of bradykinin in normal and failing human hearts.

Blais C Jr, Fortin D, Rouleau JL, Molinaro G, Adam A. Blais C Jr, et al. Among authors: adam a. J Pharmacol Exp Ther. 2000 Nov;295(2):621-6. J Pharmacol Exp Ther. 2000. PMID: 11046097

7

Kinin-dependent hypersensitivity reactions in hemodialysis: metabolic and genetic factors.

Molinaro G, Duan QL, Chagnon M, Moreau ME, Simon P, Clavel P, Lavaud S, Boileau G, Rouleau GA, Lepage Y, Adam A, Chanard J. Molinaro G, et al. Among authors: adam a. Kidney Int. 2006 Nov;70(10):1823-31. doi: 10.1038/sj.ki.5001873. Epub 2006 Sep 27. Kidney Int. 2006. PMID: 17003818 Free article.

8

The kallikrein-kinin system: current and future pharmacological targets.

Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A. Moreau ME, et al. Among authors: adam a. J Pharmacol Sci. 2005 Sep;99(1):6-38. doi: 10.1254/jphs.srj05001x. J Pharmacol Sci. 2005. PMID: 16177542 Free article. Review.

9

Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.

Gera L, Fortin JP, Adam A, Stewart JM, Marceau F. Gera L, et al. Among authors: adam a. J Pharmacol Exp Ther. 2006 Apr;317(1):300-8. doi: 10.1124/jpet.105.095661. Epub 2005 Dec 20. J Pharmacol Exp Ther. 2006. PMID: 16368899

10

The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors.

Bawolak MT, Fortin JP, Vogel LK, Adam A, Marceau F. Bawolak MT, et al. Among authors: adam a. Eur J Pharmacol. 2006 Dec 3;551(1-3):108-11. doi: 10.1016/j.ejphar.2006.08.077. Epub 2006 Sep 8. Eur J Pharmacol. 2006. PMID: 17026984

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,644 results

Search Page

Filters